Health policy
U.S. imposes new rules on ordering synthetic DNA to deter bioterrorism
The U.S. has imposed new rules on ordering synthetic DNA to deter bioterrorism, according to Science.
The original reports on this story are listed below.
More top stories
Drugs and FDA
FDA requires GLP-1 drugs to warn of rare vision-loss risk
The FDA requires all GLP-1 labels to warn of possible NAION and says patients should immediately report sudden, painless vision changes in one eye.
Drugs and FDA
Lilly’s oral GLP-1 pill reduced sleep apnea in phase 3 trials
In two 52-week phase 3 trials, orforglipron reduced sleep apnea severity versus placebo in adults with moderate to severe OSA and overweight or obesity.
Drugs and FDA
FDA approves Bayer’s Sunharbo to reduce stroke risk in certain adults
Sunharbo is approved with antiplatelet therapy to lower stroke risk after certain ischemic strokes or high-risk TIAs.